Biotech Stock Intel
Catalyst CalendarPDUFA CalendarMover SignalsCompany Screener
Disclaimer: Biotech Stock Intel is an independent research platform. Information is provided for informational purposes only and is not investment or medical advice. Always verify catalyst dates against primary sources and conduct your own research.
Biotech Stock Intel© 2026 Biotech Stock Intel
AboutMethodologyTermsPrivacy
Biotech Stock Intel
Catalyst CalendarPDUFA CalendarMover SignalsCompany Screener
Home/Stocks/MANE/Catalyst
Phase 3Data readout

Minoxidil (VDPHL01) (Potassium Channel Opener)

Male Pattern Hair Loss

MANEVeradermics
Expected catalystDecember 31, 2026Company guidance: Dec 31, 2026

Catalyst overview

Event details

Drug or asset
Minoxidil (VDPHL01) (Potassium Channel Opener)
Development stage
Phase 3
Event type
Data readout
Indication
Male Pattern Hair Loss
Research signalsHigh management interest

Research summary

What is being tracked?

This catalyst tracks a Phase 3 data readout for Minoxidil (VDPHL01) (Potassium Channel Opener) in Male Pattern Hair Loss. The expected timing is based on the latest available company guidance and may change.

Development notes

05/12/26:- Study 302 12-month data and Study 304 topline data expected H2 2026. 05/27/26:- Study 302 Part A topline results presented at WCHR May 30, 2026. 07/17/26:- Study 302 age subgroup data presented at AAD. Study 304 topline results still expected H2 2026. 08/12/26:- Study 304 topline and Study 302 12-month data remain expected H2 2026.

Verification

Primary source

Confirm timing and program details against the company announcement or filing.

Open source

More from MANE

Related pipeline programs

Phase 2/3

Minoxidil (VDPHL01) (Potassium Channel Opener)

Female Pattern Hair Loss

View company pipeline

Company

Veradermics

MANE · NYSE
Industry
Biotechnology
Pipeline assets
2
View MANE research

BioPharma Pro

Track every date change

Watchlists, source history and catalyst alerts will be available with Pro.

Start free

Updated Aug 23, 2026. Dates can change; this is not investment advice.

Disclaimer: Biotech Stock Intel is an independent research platform. Information is provided for informational purposes only and is not investment or medical advice. Always verify catalyst dates against primary sources and conduct your own research.
Biotech Stock Intel© 2026 Biotech Stock Intel
AboutMethodologyTermsPrivacy